These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6798588

  • 1. Lithium stimulates thromboxane B2 formation in human platelets.
    Imandt L, Tijhuis D, Wessels H, Haanen C, van den Berg R, Thomas C.
    Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
    [Abstract] [Full Text] [Related]

  • 2. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P, Matintalo M, Dahl ML.
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP, Little DM, Wright JT.
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [Abstract] [Full Text] [Related]

  • 4. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM, Loy A, Christea C, Weber PC, Siess W, Herberg LL, Landgraf R.
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract] [Full Text] [Related]

  • 5. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM, Landgraf R, Loy A, Weber PC, Herberg LL.
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S, Maclouf J, Caen J, Bara L, Lecrubier C, Samama M.
    J Pharmacol; 1983 Jul; 14(2):141-50. PubMed ID: 6408316
    [Abstract] [Full Text] [Related]

  • 7. OKY-1581: a selective inhibitor of thromboxane synthesis in vivo and in vitro.
    Smith JB, Jubiz W.
    Prostaglandins; 1981 Sep; 22(3):353-63. PubMed ID: 7302264
    [Abstract] [Full Text] [Related]

  • 8. Influence of strontium chloride on blood platelet function.
    Togna G, Gallozzi S, Caprino L.
    Arch Toxicol Suppl; 1989 Sep; 13():366-9. PubMed ID: 2505737
    [No Abstract] [Full Text] [Related]

  • 9. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB, Dodge JA.
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [Abstract] [Full Text] [Related]

  • 10. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
    Srivastava KC.
    Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
    [Abstract] [Full Text] [Related]

  • 11. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
    Yamaguchi A, Asakura T, Tanoue K, Yamazaki H.
    Thromb Res; 1985 Feb 01; 37(3):391-400. PubMed ID: 2986312
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G, Cerletti C, Castagnoli MN, Bertelé V, de Gaetano G.
    Biochem Pharmacol; 1985 Feb 01; 34(3):307-10. PubMed ID: 3918536
    [Abstract] [Full Text] [Related]

  • 13. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH, Nichols R, Schmeling JW, Ramwell PW.
    Thromb Res; 1981 Sep 15; 23(6):521-32. PubMed ID: 6798707
    [No Abstract] [Full Text] [Related]

  • 14. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
    Beatty CH, Howard CF, Hoskins MK, Herrington PT.
    Atherosclerosis; 1985 Apr 15; 55(1):1-13. PubMed ID: 3924062
    [Abstract] [Full Text] [Related]

  • 15. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM, Seachord CL, Holmsen H, Smith JB, Prieur DJ.
    Nature; 1979 Nov 15; 282(5736):331-3. PubMed ID: 503210
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK, Rao AK, Willis J, Colman RW.
    Proc Natl Acad Sci U S A; 1983 Oct 15; 80(19):6086-90. PubMed ID: 6577468
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC, Ghali NI, Venton DL, Le Breton GC.
    Prostaglandins; 1982 Aug 15; 24(2):195-206. PubMed ID: 6293001
    [Abstract] [Full Text] [Related]

  • 18. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
    Agradi E, Petroni A, Socini A, Galli C.
    Prostaglandins; 1981 Aug 15; 22(2):255-66. PubMed ID: 6794104
    [Abstract] [Full Text] [Related]

  • 19. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH, Kuo SC, Huang LJ, Huang TF, Teng CM.
    Thromb Res; 1992 Apr 01; 66(1):61-73. PubMed ID: 1412184
    [Abstract] [Full Text] [Related]

  • 20. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M, Felisi O, Boukhchache D, Sicard B, Dechavanne M.
    Thromb Res; 1984 Jul 15; 35(2):141-7. PubMed ID: 6089369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.